Suppr超能文献

住院癌症手术患者医院死亡率的差异

Variation in hospital mortality rates with inpatient cancer surgery.

作者信息

Wong Sandra L, Revels ShaʼShonda L, Yin Huiying, Stewart Andrew K, McVeigh Andrea, Banerjee Mousumi, Birkmeyer John D

机构信息

*Center for Healthcare Outcomes and Policy and Department of Surgery, University of Michigan Medical School, Ann Arbor †Remedy Informatics, Chicago, IL; and ‡Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor.

出版信息

Ann Surg. 2015 Apr;261(4):632-6. doi: 10.1097/SLA.0000000000000690.

Abstract

OBJECTIVE

To elucidate clinical mechanisms underlying variation in hospital mortality after cancer surgery

BACKGROUND

: Thousands of Americans die every year undergoing elective cancer surgery. Wide variation in hospital mortality rates suggest opportunities for improvement, but these efforts are limited by uncertainty about why some hospitals have poorer outcomes than others.

METHODS

Using data from the 2006-2007 National Cancer Data Base, we ranked 1279 hospitals according to a composite measure of perioperative mortality after operations for bladder, esophagus, colon, lung, pancreas, and stomach cancers. We then conducted detailed medical record review of 5632 patients at 1 of 19 hospitals with low mortality rates (2.1%) or 30 hospitals with high mortality rates (9.1%). Hierarchical logistic regression analyses were used to compare risk-adjusted complication incidence and case-fatality rates among patients experiencing serious complications.

RESULTS

The 7.0% absolute mortality difference between the 2 hospital groups could be attributed to higher mortality from surgical site, pulmonary, thromboembolic, and other complications. The overall incidence of complications was not different between hospital groups [21.2% vs 17.8%; adjusted odds ratio (OR) = 1.34, 95% confidence interval (CI): 0.93-1.94]. In contrast, case-fatality after complications was more than threefold higher at high mortality hospitals than at low mortality hospitals (25.9% vs 13.6%; adjusted OR = 3.23, 95% CI: 1.56-6.69).

CONCLUSIONS

Low mortality and high mortality hospitals are distinguished less by their complication rates than by how frequently patients die after a complication. Strategies for ensuring the timely recognition and effective management of postoperative complications will be essential in reducing mortality after cancer surgery.

摘要

目的

阐明癌症手术后医院死亡率差异背后的临床机制

背景

每年有成千上万的美国人在接受择期癌症手术时死亡。医院死亡率差异很大,这表明有改进的空间,但由于不确定为何有些医院的治疗结果比其他医院差,这些努力受到了限制。

方法

利用2006 - 2007年国家癌症数据库的数据,我们根据膀胱癌、食管癌、结肠癌、肺癌、胰腺癌和胃癌手术后围手术期死亡率的综合指标,对1279家医院进行了排名。然后,我们对19家低死亡率(2.1%)医院或30家高死亡率(9.1%)医院中的5632例患者的病历进行了详细审查。采用分层逻辑回归分析比较发生严重并发症患者的风险调整后并发症发生率和病死率。

结果

两组医院7.0%的绝对死亡率差异可归因于手术部位、肺部、血栓栓塞和其他并发症导致的较高死亡率。两组医院的总体并发症发生率没有差异[21.2%对17.8%;调整优势比(OR)= 1.34,95%置信区间(CI):0.93 - 1.94]。相比之下,高死亡率医院并发症后的病死率比低死亡率医院高出三倍多(25.9%对13.6%;调整OR = 3.23,95% CI:1.56 - 6.69)。

结论

低死亡率和高死亡率医院的区别不在于并发症发生率,而在于并发症后患者死亡的频率。确保及时识别和有效管理术后并发症的策略对于降低癌症手术后的死亡率至关重要。

相似文献

3
Colon cancer operations at high- and low-mortality hospitals.高死亡率和低死亡率医院的结肠癌手术
Surgery. 2016 Aug;160(2):359-65. doi: 10.1016/j.surg.2016.04.035. Epub 2016 Jun 14.

引用本文的文献

1
Shared Decision-Making in Pancreatic Surgery.胰腺手术中的共同决策
Ann Surg Open. 2022 Aug 17;3(3):e196. doi: 10.1097/AS9.0000000000000196. eCollection 2022 Sep.
8
Strengths and Limitations of Registries in Surgical Oncology Research.外科肿瘤学研究中注册研究的优势和局限性。
J Gastrointest Surg. 2021 Nov;25(11):2989-2996. doi: 10.1007/s11605-021-05094-y. Epub 2021 Sep 10.

本文引用的文献

2
10
Classifying cause of death after cancer surgery.癌症手术后死因的分类。
Surg Innov. 2006 Dec;13(4):274-9. doi: 10.1177/1553350606296723.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验